United States Non Invasive Prenatal Testing Market

More Details @ http://www.dpiresearch.com/report-details.php?P_ID=127

The report titled “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 – 2023” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in United States. The research includes historic data from 2015 to 2017 and forecasts until 2023.

Long–term Growth Projection:

•    United States is anticipated to be the most attractive market in the
Non-Invasive Prenatal Testing(NIPT) industry
•    United States Non-Invasive Prenatal Testing(NIPT) is expected to
register a faster value growth during 2018 – 2023
•    The Potential United States Non-Invasive Prenatal Testing(NIPT) Market
is set to cross USD 2.5 Billion by 2023
•    MaterniT21 PLUS, Harmony, Verifi, Panorama are the popular test in the
United States Non-Invasive Prenatal Testing(NIPT) Market

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2023. The report also includes assessment of comparative test analysis by companies. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT test market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche)

Major and Promising NIPT test covered in the report are as follows:

MaterniT21 PLUS, VisibiliT, MaterniT21 GENOME, Harmony, Verifi, Panorama, Vistara and QNatal Advanced

The Latest Industry Data Included in this Report:

•    Actual NIPT Test Volume & Market Revenue (2015 – 2023)
•    Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
•    High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
•    Potential NIPT Test Volume & Market Revenue (2015 – 2023)
•    Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
•    High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
•    NIPT Test Market – Reimbursement & Regulation System
•    NIPT Test Implementation in High–Income Countries
•    Comparative Test Analysis – By Companies
•    Major Deals in Non–Invasive Prenatal Testing Market
•    Key Companies Analysis
•    Key Market Drivers and Inhibitors of the United States NIPT Test Market

Market Research Reports @ 30% Discount

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.
DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.
DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Global Neuromodulation Market Research Report 2018

Global Neuromodulation market is set to surpass US$ 7 Billion by 2025.
With such an extensive therapeutic scope, and immense ongoing enhancements in biotechnology, neuromodulation will likely be a leading growth industry over the forecast period. The growth of the sector is largely stimulated by an increased uptake of neuromodulation devices, surging prevalence of diseases pertaining to neuromodulation, ageing population, technological advances and deal making activity globally.
The report titled “Global Neuromodulation Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the Global Neuromodulation Market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as application, technology, geography, company and competitive landscape. A comprehensive analysis has been done on market share of all the categories. Key trends in terms of merger & acquisitions, collaborations, partnerships and agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the Neuromodulation market.
The report concludes with the profiles of major players in the Neuromodulation market. The major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and recent development of the Neuromodulation market.
Further key findings from the report suggest:
• North America is the most attractive market in the neuromodulation market
• Chronic pain is the major application segment of the neuromodulation market
• With regard to technology, spinal cord stimulation represents the largest segment of the neuromodulation market
• The APAC marketplace is slated to grow at the highest rate, and China, India and Japan will be major igniters
Market Segmentation: Global Neuromodulation Market
The global neuromodulation market has been segmented on the basis of technology, application, geography and company
Neuromodulation Market, by Technology
• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation (VNS)
• Other Technologies
Neuromodulation Market, by Application
 
• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression (TRD)
• Obsessive Compulsive Disorder (OCD)
• Other Applications
Neuromodulation Market, by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)
Neuromodulation Market, by Company
• Medtronic
• Boston Scientific
• St. Jude Medical (Abbott)
• Liva Nova
• Nevro
• Other Companies